The 7th Asian Network Meeting was held on April 23, combining both online and offline participation. Huang Guo, deputy commissioner of China's National Medical Products Administration (NMPA), delivered an online speech.

Huang noted that in recent years, China NMPA has promoted the formulation and introduction of a series of measures aimed at comprehensively deepening the reform on drug and medical device regulation. These efforts have supported the high-quality development of the pharmaceutical industry and ensured high-level safety of drugs, Huang added. He expressed the hope that the meeting would further promote exchanges and cooperation in drug regulation across the Asian region.

At the meeting, drug regulatory authorities from nine countries—China, India, Indonesia, Japan, South Korea, Malaysia, the Philippines, Singapore and Thailand—shared updates on their latest regulatory developments and engaged in in-depth discussions on topics such as tackling current challenges in clinical trials and advancing regulatory reliance and convergence.

Officials from relevant departments and affiliated institutions of the NMPA attended the meeting.